AUM BIOSCIENCES
AUM Biosciences is an oncology-focused biotechnology company that aims to accelerate the development of innovative, affordable medicines for patients in Asia and around the world. AUM Biosciences focuses on early-stage development of innovative medicines for the treatment of Asian-prevalent cancers.
AUM BIOSCIENCES
Social Links:
Industry:
Biotechnology Oncology
Founded:
2018-01-01
Address:
Singapore, Central Region, Singapore
Country:
Singapore
Website Url:
http://www.aumbiosciences.com
Total Employee:
11+
Status:
Active
Contact:
+65 6808 6034
Total Funding:
28.48 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Apple Mobile Web Clips Icon Google Font API WordPress Font Awesome IPv6 Contact Form 7 WPForms Akamai Hosted
Similar Organizations
Acrivon Therapeutics
Acrivon Therapeutics is a precision oncology therapeutics company specializing in drug development through early clinical treatment success.
Avant Meats
Avant Meats is a technology company with patent-pending solutions to produce animal meat and protein without the animal
Avstera Therapeutics
Avstera Therapeutics is an oncology-focused biotech company that fulfil unmet needs of cancer patients.
Geneos Therapeutics
Geneos Therapeutics is a developer of a neo-antigen based personalized immunotherapy designed to offer cancer treatment.
Eden Biologics
Eden Biologics is a biopharmaceutical company that develops biosimilars and accelerates the development programs for clients & partners.
Leap Therapeutics
Leap Therapeutics is a clinical-stage biopharmaceutical company.
Pinpoint Therapeutics
Pinpoint Therapeutics is a preclinical stage company developing novel cancer treatment options aimed to specifically inhibit autophagy.
Current Employees Featured
Founder
Investors List
Everlife
Everlife investment in Series A - AUM Biosciences
SPRIM
SPRIM investment in Series A - AUM Biosciences
The Agency for Science, Technology and Research
The Agency for Science, Technology and Research investment in Series A - AUM Biosciences
Official Site Inspections
http://www.aumbiosciences.com Semrush global rank: 11.97 M Semrush visits lastest month: 138
- Host name: 192.194.178.68.host.secureserver.net
- IP address: 68.178.194.192
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260
More informations about "AUM Biosciences"
About – Aum
Industry veterans with successful track records in developing & commercializing innovative cancer therapiesSee details»
Overview – Aum
AUM Biosciences is a global clinical-stage biotech company, focused on discovering, developing and advancing a pipeline of precision oncology therapeutics designed to deploy multi-faceted inhibition strategies to reverse …See details»
AUM Biosciences - LinkedIn
AUM Biosciences | 2,865 followers on LinkedIn. Advancing precision oncology therapeutics designed to deploy multi-faceted inhibition to reverse cancer resistance | AUM Biosciences is focused on ...See details»
AUM Biosciences - Crunchbase Company Profile
AUM Biosciences is committed to addressing the unmet medical needs by developing innovative and affordable oncology therapeutics for Asia.See details»
AUM BIOSCIENCES INC. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for AUM BIOSCIENCES INC. of Potomac, MD. Get the latest business insights from Dun & Bradstreet.See details»
AUM Biosciences | VentureRadar
AUM Biosciences is at the forefront of disrupting the drug development process in oncology, to deliver pioneering and affordable targeted drugs across a broad spectrum of cancers. AUM is …See details»
AUM BIOSCIENCES PTE. LTD. (201810204D) - Singapore Company
Mar 26, 2018 AUM BIOSCIENCES PTE. LTD. was incorporated on 26 March 2018 (Monday) as a Private Company Limited by Shares in Singapore. The Company current operating status is …See details»
Our Story – Aum
AUM is focused on developing a robust industry leading pipeline of best-in-class and first-in-class small molecule therapies, leveraging the latest in precision and digital medicine tools. Our core mandate of being biomarker driven, using …See details»
AUM Biosciences - lifesciencehistory.com
AUM is a global clinical-stage oncology company focused on advancing a pipeline of precision oncology therapeutics designed to deploy multi-faceted inhibition strategies to reverse cancer …See details»
AUM Biosciences - Craft
AUM Biosciences has 5 employees across 4 locations. See insights on AUM Biosciences including office locations, competitors, revenue, financials, executives, subsidiaries and more …See details»
AUM Biosciences - PharmaBoardroom
Jun 11, 2019 Company info AUM Biosciences is at the forefront of disrupting the drug development process in oncology, to deliver pioneering and affordable targeted drugs across a …See details»
AUM Biosciences announces closing of $27 million in a “Series
Oct 12, 2021 AUM was founded to enable a holistic strategy for drug development and improving the probability of success with a focus on synergism, sustainability, and scalability. …See details»
AUM Biosciences Pte Ltd | F6S
AUM Biosciences is founded by industry veterans who have a track record of executing a $145M PE deal to support pharmaceutical giant Eisai, leading to the global commercialization of 3 …See details»
Career – Aum
AUM Biosciences is built and led by a team of visionaries and industry veterans with decades of research and healthcare experience. Our work culture stems from integrity, transparency and …See details»
AUMBiosciences - F6S
About AUMBiosciences AUM Biosciences is founded by industry veterans who have a track record of executing a $145M PE deal to support pharmaceutical giant Eisai leading to the …See details»
AUM Biosciences - VentureRadar
AUM Biosciences is at the forefront of disrupting the drug development process in oncology, to deliver pioneering and affordable targeted drugs across a broad spectrum of cancers. AUM is …See details»
AUM Biosciences - VentureRadar
"AUM Biosciences is at the forefront of disrupting the drug development process in oncology, to deliver pioneering and affordable targeted drugs across a broad spectrum of cancers. AUM is …See details»
Establishing Canada’s first large-scale bioinnovation centre
Mar 20, 2025 The Neptune BioInnovation Centre (NBC), a 51,000 sq ft facility on a 12.3 acre lot in Dartmouth, will offer leasable wet and dry lab space, warehouse and office spaces, and …See details»
AUM Biosciences 2025 Company Profile: Valuation, Funding
Information on valuation, funding, cap tables, investors, and executives for AUM Biosciences. Use the PitchBook Platform to explore the full profile.See details»
Clinical Trials – Aum
Clinical trials are a benchmark to test the efficiency and safety of drug therapies throughout the drug design process. As thousands of patients volunteer across all three phases of drug …See details»